---
schema_version: "secwatch.filing_event.v1"
accession: "0001615219-26-000016"
form_type: "8-K"
ticker: "DCOY"
cik: "0001615219"
company_name: "Decoy Therapeutics Inc."
filed_at: "2026-09-15T21:00:40+00:00"
generated_at: "2026-09-15T21:02:13.645008+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Decoy Therapeutics shareholders approve warrant issuance and authorized share reduction

## Summary
- Special meeting held 9/14/2026; quorum 46.03% of 590,185 shares outstanding.
- Proposal 1 passed: 81,646 for, 2,906 against, 196 abstain approving Milestone Warrant share issuance.
- Proposal 2 passed: 234,494 for, 6,303 against, 181 abstain to cut authorized shares by 10M to 90M.
- Adjournment proposal moot since both proposals approved by majority of votes cast.

## SEC filing metadata
- accession: 0001615219-26-000016
- form_type: 8-K
- ticker: DCOY
- cik: 0001615219
- company_name: Decoy Therapeutics Inc.
- filed_at: 2026-09-15T21:00:40+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1615219/000161521926000016/0001615219-26-000016-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1615219/000161521926000016/dcoy-20260914.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001615219-26-000016
- JSON: https://secwatch.observer/filing/0001615219-26-000016.json
- Plain text: https://secwatch.observer/filing/0001615219-26-000016.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.